Keryx Biopharmaceuticals, Inc.

(NASDAQ:KERX)

Key Stats & Ratios

Valuation
Market Cap 10.48M
P/E
P/E (Trailing) -0.12
P/E (Forward)
Price/Sales 5.75
Price/Book 23.00
EPS -1.78
EPS Growth (ttm)
Fiscal Year
Fiscal Year Ends Dec 31
Last Quarter Jun 2008
Profitability
Operating Income -77559000.00
Net Income -78335000.00
Profit Margin (ttm)
Operating Margin (ttm) -41.67%
Management Effectiveness
Return on Assets (ttm) -255.10%
Return on Equity (ttm)
EBIT Margin (ttm)
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 3.65M
Revenue 1.86M
Revenue/Share 0.04
Revenue Growth (ytd) 563.90%
Annual Revenue Growth Rate (3Y) 42.98%
Annual Income Growth Rate (3Y)
Earnings Growth (ytd)
Gross Operating Profit (ttm) 1.92M
EBITDA -77439000.00
Diluted EPS (ttm) -1.78
Balance Sheet
Total Cash 6.80M
Total Cash/Share 0.15
Total Assets 30.70M
Total Liabilities 30.38M
Total Debt/Equity
Long Term Debt Common Equity Ratio
Current Ratio 2.00
Leverage Ratio 95.00
Book Value/Share 0.01
Cash Flow
Cash Flow -78215000.00
Free Cash Flow -35537000.00
Cash Flow/Share -1.72
Free Cash Flow/Share -0.78

Trading Information

Stock Price History
Beta
52Wk Change -97.30%
52Wk Change Vs. Mkt -96.00%
52Wk High 8.86
52Wk Low 0.10
10 Day Moving Average 0.22
200 Day Moving Average 0.38
Share Statistics
Average Volume 473.20K
Shares Outstanding 45.35M
Shares Float 42.27M
% Held by Insiders 6.80%
% Held by Institutions 38.60%
Shares Short (As of Dec 10, 2008) 1.41M
Short Ratio 2.60
Short % of Float 3.30%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount